A Gammaherpesvirus Uses Alternative Splicing to Regulate Its Tropism and Its Sensitivity to Neutralization

English version České info

Human gammaherpesviruses are associated with the development of lymphomas and epithelial malignancies. The heterogeneity of these tumors reflects the ability of these viruses to route infection to different cell types at various stages of their lifecycle. While the Epstein Barr virus uses gp42 – human leukocyte antigen class II interaction as a switch of cell tropism, the molecular mechanism that orientates tropism of rhadinoviruses is still poorly defined. Here, we used bovine herpesvirus 4 (BoHV-4) to further elucidate how rhadinoviruses regulate their infectivity. In the absence of any gp42 homolog, BoHV-4 exploits the alternative splicing of its Bo10 gene to produce distinct viral populations that behave differently based on the originating cell. While epithelial cells produce virions with high levels of the accessory envelope protein gp180, encoded by a Bo10 spliced product, myeloid cells express reduced levels of gp180. As a consequence, virions grown in epithelial cells are hardly infectious for CD14+ circulating cells, but are relatively resistant to antibody neutralization due to the shielding property of gp180 for vulnerable entry epitopes. In contrast, myeloid virions readily infect CD14+ circulating cells but are easily neutralized. This molecular switch could therefore allow BoHV-4 to promote either, on the one hand, its dissemination into the organism, or, on the other hand, its transmission between hosts.

Vyšlo v časopise: A Gammaherpesvirus Uses Alternative Splicing to Regulate Its Tropism and Its Sensitivity to Neutralization. PLoS Pathog 9(10): e32767. doi:10.1371/journal.ppat.1003753
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003753

Souhrn

Zdroje

1. HenleG, HenleW, CliffordP, DiehlV, KafukoGW, et al. (1969) Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43: 1147–1157.

2. VermaSC, RobertsonES (2003) Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett 222: 155–163.

3. YoungLS, RickinsonAB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757–768.

4. MesriEA, CesarmanE, BoshoffC (2010) Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10: 707–719.

5. HeldweinEE, KrummenacherC (2008) Entry of herpesviruses into mammalian cells. Cell Mol Life Sci 65: 1653–1668.

6. ConnollySA, JacksonJO, JardetzkyTS, LongneckerR (2011) Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol 9: 369–381.

7. GilletL, MayJS, ColacoS, StevensonPG (2007) Glycoprotein L disruption reveals two functional forms of the murine gammaherpesvirus 68 glycoprotein H. J Virol 81: 280–291.

8. Hutt-FletcherLM (2007) Epstein-Barr virus entry. J Virol 81: 7825–7832.

9. TannerJ, WeisJ, FearonD, WhangY, KieffE (1987) Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50: 203–213.

10. Shannon-LoweCD, NeuhierlB, BaldwinG, RickinsonAB, DelecluseHJ (2006) Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A 103: 7065–7070.

11. TurkSM, JiangR, ChesnokovaLS, Hutt-FletcherLM (2006) Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells. J Virol 80: 9628–9633.

12. SpriggsMK, ArmitageRJ, ComeauMR, StrockbineL, FarrahT, et al. (1996) The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J Virol 70: 5557–5563.

13. MullenMM, HaanKM, LongneckerR, JardetzkyTS (2002) Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell 9: 375–385.

14. KirschnerAN, SoremJ, LongneckerR, JardetzkyTS (2009) Structure of Epstein-Barr virus glycoprotein 42 suggests a mechanism for triggering receptor-activated virus entry. Structure 17: 223–233.

15. WangX, KenyonWJ, LiQ, MullbergJ, Hutt-FletcherLM (1998) Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol 72: 5552–5558.

16. LiQ, SpriggsMK, KovatsS, TurkSM, ComeauMR, et al. (1997) Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71: 4657–4662.

17. WangX, Hutt-FletcherLM (1998) Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J Virol 72: 158–163.

18. BorzaCM, Hutt-FletcherLM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8: 594–599.

19. Hutt-FletcherLM, ChesnokovaLS (2010) Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection. Virulence 1: 395–398.

20. RaabMS, AlbrechtJC, BirkmannA, YagubogluS, LangD, et al. (1998) The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol 72: 6725–6731.

21. StewartJP, JanjuaNJ, PepperSD, BennionG, MackettM, et al. (1996) Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol 70: 3528–3535.

22. MachielsB, LeteC, de FaysK, MastJ, DewalsB, et al. (2011) The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects. J Virol 85: 1011–1024.

23. de LimaBD, MayJS, StevensonPG (2004) Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol 78: 5103–5112.

24. WangFZ, AkulaSM, PramodNP, ZengL, ChandranB (2001) Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75: 7517–7527.

25. GilletL, AdlerH, StevensonPG (2007) Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS One 2: e347.

26. BlasigC, ZietzC, HaarB, NeipelF, EsserS, et al. (1997) Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 71: 7963–7968.

27. FabianK, IvanicsR, TerenyiM, EgyedL (2005) Detection of bovine herpesvirus 4 in CD11b+ leukocytes of experimentally infected rabbits. Acta Vet Hung 53: 265–273.

28. ZimmermannW, BrollH, EhlersB, BuhkHJ, RosenthalA, et al. (2001) Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication. J Virol 75: 1186–1194.

29. Thorley-LawsonDA, PoodryCA (1982) Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. J Virol 43: 730–736.

30. MachielsB, LeteC, GuillaumeA, MastJ, StevensonPG, et al. (2011) Antibody evasion by a gammaherpesvirus O-glycan shield. PLoS Pathog 7: e1002387.

31. KolsetSO (1987) Proteoglycans in normal and neoplastic monocytes. Exp Cell Res 168: 318–324.

32. MilhoR, FredericoB, EfstathiouS, StevensonPG (2012) A heparan-dependent herpesvirus targets the olfactory neuroepithelium for host entry. PLoS Pathog 8: e1002986.

33. FrancoisS, VidickS, SarletM, DesmechtD, DrionP, et al. (2013) Illumination of Murine Gammaherpesvirus-68 Cycle Reveals a Sexual Transmission Route from Females to Males in Laboratory Mice. PLoS Pathog 9: e1003292.

34. HadinotoV, ShapiroM, SunCC, Thorley-LawsonDA (2009) The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5: e1000496.

35. MayJS, ColemanHM, SmillieB, EfstathiouS, StevensonPG (2004) Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol 85: 137–146.

36. FredericoB, MilhoR, MayJS, GilletL, StevensonPG (2012) Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4. PLoS Pathog 8: e1002935.

37. DasSR, HensleySE, InceWL, BrookeCB, SubbaA, et al. (2013) Defining influenza a virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe 13: 314–323.

38. SattentauQ (2008) Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 6: 815–826.

39. SanchezA, TrappierSG, MahyBW, PetersCJ, NicholST (1996) The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 93: 3602–3607.

40. ItoH, WatanabeS, TakadaA, KawaokaY (2001) Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol 75: 1576–1580.

41. MohanGS, LiW, YeL, CompansRW, YangC (2012) Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus. PLoS Pathog 8: e1003065.

42. BirkmannA, MahrK, EnsserA, YagubogluS, TitgemeyerF, et al. (2001) Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol 75: 11583–11593.

43. ConchaM, WangX, CaoS, BaddooM, FewellC, et al. (2012) Identification of new viral genes and transcript isoforms during Epstein-Barr virus reactivation using RNA-Seq. J Virol 86: 1458–1467.

44. Stern-GinossarN, WeisburdB, MichalskiA, LeVT, HeinMY, et al. (2012) Decoding human cytomegalovirus. Science 338: 1088–1093.

45. GathererD, SeirafianS, CunninghamC, HoltonM, DarganDJ, et al. (2011) High-resolution human cytomegalovirus transcriptome. Proc Natl Acad Sci U S A 108: 19755–19760.

46. van BeurdenSJ, GathererD, KerrK, GalbraithJ, HerzykP, et al. (2012) Anguillid herpesvirus 1 transcriptome. J Virol 86: 10150–10161.

47. JarosinskiKW, OsterriederN (2012) Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission. J Virol 86: 7896–7906.

48. ThiryE, PastoretPP, Dessy-DoizéC, HanzenC, Calberg-BacqCM (1981) Herpesvirus in infertile bull's testicle. Vet rec 108: 426.

49. GilletL, DaixV, DonofrioG, WagnerM, KoszinowskiUH, et al. (2005) Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. J Gen Virol 86: 907–917.

50. DonofrioG, van SantenVL (2001) A bovine macrophage cell line supports bovine herpesvirus-4 persistent infection. J Gen Virol 82: 1181–1185.

51. PalmeiraL, MachielsB, LeteC, VanderplasschenA, GilletL (2011) Sequencing of bovine herpesvirus 4 v.test strain reveals important genome features. Virol J 8: 406.

52. LeteC, MachielsB, StevensonPG, VanderplasschenA, GilletL (2012) Bovine herpesvirus type 4 glycoprotein L is nonessential for infectivity but triggers virion endocytosis during entry. J Virol 86: 2653–2664.